74 related articles for article (PubMed ID: 1981805)
1. Release of the vascular permeability factor in minimal change nephrotic syndrome is related to CD4+ lymphocytes.
Tomizawa S; Nagasawa N; Maruyama K; Shimabukuro N; Arai H; Kuroume T
Nephron; 1990; 56(3):341-2. PubMed ID: 1981805
[No Abstract] [Full Text] [Related]
2. Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome.
Maruyama K; Tomizawa S; Seki Y; Arai H; Kuroume T
Nephron; 1992; 62(1):27-30. PubMed ID: 1436287
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
Matsumoto K; Ohi H; Kanmatsuse K
Nephron; 1999; 82(1):32-8. PubMed ID: 10224482
[TBL] [Abstract][Full Text] [Related]
5. FK 506 for vascular permeability factor production in minimal change nephrotic syndrome.
Maruyama K; Tomizawa S; Seki Y; Arai H; Ogawa T; Kuroume T
Nephron; 1994; 66(4):486-7. PubMed ID: 7517020
[No Abstract] [Full Text] [Related]
6. The vascular permeability factor is a T lymphocyte product.
Heslan JM; Branellec A; Laurent J; Lagrue G
Nephron; 1986; 42(2):187-8. PubMed ID: 3484808
[No Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor in human milk.
Hoshimoto K; Ohkura T
Br J Biomed Sci; 2000; 57(3):215-7. PubMed ID: 11050773
[No Abstract] [Full Text] [Related]
8. [Hair follicles and vascular endothelial growth factor].
Lachgar S; Charvéron M; Aries MF; Gall Y; Bonafé JL
Ann Dermatol Venereol; 1998 Apr; 125(4):271-4. PubMed ID: 9747267
[No Abstract] [Full Text] [Related]
9. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular permeability factor in reactive astrocytes surrounding malignant gliomas.
Vaquero J; Zurita M; Oya S
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):339-41. PubMed ID: 12175347
[No Abstract] [Full Text] [Related]
11. Vascular permeability/vascular endothelial growth factors: a potential role in the pathogenesis and treatment of vascular diseases.
Williams B
Vasc Med; 1996; 1(4):251-8. PubMed ID: 9552580
[No Abstract] [Full Text] [Related]
12. Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor.
Agrawal R; Chimusoro K; Payne N; van der Spuy Z; Jacobs HS
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):141-4. PubMed ID: 9204237
[No Abstract] [Full Text] [Related]
13. [Vascular endothelial growth factor in the aqueous humor in diabetic retinopathy and other diseases of the retina].
Pfeiffer A
Dtsch Med Wochenschr; 1995 Oct; 120(42):1453. PubMed ID: 7555678
[No Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor in patients with acute asthma.
Lee YC; Lee HK
J Allergy Clin Immunol; 2001 Jun; 107(6):1106. PubMed ID: 11398093
[No Abstract] [Full Text] [Related]
15. Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.
Modi J; Patel A; Terrell R; Tuttle RM; Francis GL
J Clin Endocrinol Metab; 2003 Sep; 88(9):4418-25. PubMed ID: 12970319
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas.
Lafuente JV; Adán B; Alkiza K; Garibi JM; Rossi M; Cruz-Sánchez FF
J Mol Neurosci; 1999; 13(1-2):177-85. PubMed ID: 10691304
[TBL] [Abstract][Full Text] [Related]
17. [Expression of vascular endothelial cell growth factor as a predictor of recurrence in gastric carcinoma].
Maeda K; Chung YS; Ogawa Y; Ko T; Ogawa M; Onoda N; Kato Y; Arimoto Y; Nitta A; Sowa M
Gan To Kagaku Ryoho; 1995 Apr; 22(5):699-701. PubMed ID: 7717726
[No Abstract] [Full Text] [Related]
18. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome.
Cheong HI; Lee JH; Hahn H; Park HW; Ha IS; Choi Y
J Nephrol; 2001; 14(4):263-9. PubMed ID: 11506248
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in patients suffering from thrombangitis obliterans.
Brodmann M; Renner W; Stark G; Seinost G; Pilger E
Int J Cardiol; 2001; 80(2-3):185-6. PubMed ID: 11578712
[No Abstract] [Full Text] [Related]
20. Molecular and biological properties of the vascular endothelial growth factor family of proteins.
Ferrara N; Houck K; Jakeman L; Leung DW
Endocr Rev; 1992 Feb; 13(1):18-32. PubMed ID: 1372863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
